Condition
Graft Failure clinical trials and research
As of November 12, 2026, Find a Trial lists 12 Graft Failure clinical trials that are recruiting, at sites in 7 countries (most in United States (5), China (2), Italy (1)). By phase: Phase 1/2 (1), Phase 2 (1), Early Phase 1 (1), Phase 4 (1). There are also 10 NIH-funded research projects on Graft Failure, with $6.3 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 12Clinical trials
- 10NIH research projects
- 7Countries
Newest Graft Failure clinical trials
All recruiting trials (12)
-
Differences in Outcomes After Allograft vs Autograft in Revision ACL Repair
This study looks at whether using donor tissue (allograft) versus the patient’s own tissue (autograft) in revision ACL surgery leads to different results.
-
Ruxolitinib-enhanced haploidentical transplant for children and young adults with sickle cell disease
This trial will test whether adding ruxolitinib to a reduced-intensity haploidentical transplant lowers the risk of graft failure in children and young adults with sickle cell disease.
-
Preventing graft rejection after allogeneic stem cell transplant
This trial will try the drug emapalumab to see if it can prevent graft rejection in people judged high risk after allogeneic hematopoietic stem cell transplant.
-
Donor transplant for high risk blood disorders
This study is testing if a stem cell transplant from a matched sibling can help people with high-risk blood disorders like sickle cell disease and thalassemia feel better.
-
Investigating graft failure after heart bypass surgery
This study looks at why heart bypass grafts fail by using special scans and tests on people who have had the surgery and those who might have problems with their grafts.
-
Comparing immunosuppression strategies in patients with late renal graft failure
This study is testing whether continuing low-dose immunosuppression or stopping it after six months is better for people with late kidney transplant failure.
-
Using CD34+ Selected Stem Cells to Treat Graft Failure
This study is testing if using special stem cells can help people who have had a stem cell transplant and are experiencing problems with their graft.
-
Modified second transplantation for patients with graft failure
This study is testing a new approach to a second stem cell transplant for patients who didn't fully recover after their first transplant to see if it helps them get better, especially with their platelet counts.
-
Second haploidentical stem cell transplantation for graft failure
This study is testing if a second stem cell transplant from a partially matched donor can help patients with blood cancers who had problems with their first transplant.
-
One-year comparison of radial artery versus no-touch saphenous vein grafts in women having coronary bypass surgery
This test compares whether a radial artery graft or a 'no-touch' saphenous vein graft stays open better for one year in women undergoing coronary bypass surgery.
-
Using donor-derived DNA and immune cells to predict kidney transplant rejection
This study is testing if measuring certain DNA and immune cells from kidney donors can help predict if a kidney transplant will be rejected by the recipient's body.
-
Evaluating heart patients with previous bypass surgery for graft issues and heart disease progression
This study is trying to see how heart patients who had bypass surgery and are having chest pain again are doing over time, especially looking at issues with their grafts and heart disease.
NIH-funded research (10)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Targeted NAD+ Replenishment to Protect Vein Grafts After Bypass
Aims to protect vein grafts used in bypass surgery by delivering NAD+ directly to vascular cells to reduce failure from aging and injury.
-
Gene therapy to protect vein grafts after bypass surgery
Testing a gene therapy meant to help veins used in bypass operations stay open longer for people with coronary or peripheral artery disease.
-
Targeted gene therapy to protect prosthetic leg bypass grafts
This project uses targeted gene-silencing treatments to prevent narrowing and failure of synthetic bypass grafts in people with blocked leg arteries.
-
Improving vein graft success after heart bypass surgery
This project uses computer models to design better ways to prevent vein grafts from failing after coronary artery bypass surgery.
-
Gene therapies to prevent vein graft failure in heart and leg surgeries
This study is looking at a new way to help improve the success of vein grafts used in heart and leg surgeries, especially for people with coronary artery disease and peripheral arterial disease, by using a special gene therapy that could help keep the grafts healthy and working better for longer.
-
Understanding why transplanted hearts fail over time
This study is looking at how heart transplants can sometimes fail over time, especially when the heart muscle gets too thick, and it aims to understand the different types of cells involved in this process to help improve the health and longevity of transplanted hearts for patients.
-
Gene therapies to prevent failure of prosthetic bypass grafts
This study is looking at a new way to help people with severe leg artery blockages by using a special treatment to improve the success of prosthetic grafts, which can sometimes fail and lead to serious problems like losing a limb.
-
Using computer models to improve vein graft success after heart surgery
This study is looking for ways to help heart surgery patients by finding out how special coverings can keep vein grafts from failing after surgery, making the recovery process smoother and more successful.
-
Using imaging and blood tests to predict transplant failure after stem cell transplants
This study is looking at new ways to spot early signs of graft failure in patients who have had a stem cell transplant, using special imaging and blood tests to help doctors catch problems sooner and provide better care, especially for those getting cord blood or family donor transplants.
-
Using a 3D printed device to prevent vein graft failure after heart surgery
This study is testing a new biodegradable device that helps keep vein grafts working well after heart surgery, aiming to help many patients avoid complications and improve their recovery.
Related topics
Quick answers
How many Graft Failure clinical trials are recruiting right now?
12, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 7 countries. The most sites are in United States (5 trials), China (2 trials), Italy (1 trial), Brazil (1 trial), Netherlands (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 2: 1, Early Phase 1: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.